Online pharmacy PharmEasy is aiming to return to Dalal Street this year, two years after withdrawing its initial public offering (IPO) application, people familiar with the matter said. The company plans to discuss its IPO strategy with its board next month, including the possibility of a reverse merger with its listed subsidiary Thyrocare, they said. Read more at: https://retail.economictimes.indiatimes.com/news/health-and-beauty/pharmacy/pharmeasy-to-formally-discuss-ipo-plans-with-its-board-in-second-try/117411842?ag=wappchnl&utm_source=wappchnl